| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 753-763, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
MC van Bruggen, K Kramers, MN Hylkema, J van den Born, MA Bakker, KJ Assmann, RJ Smeenk and JH Berden
Department of Nephrology, University Hospital Nijmegen, The Netherlands.
Recently we found in biopsies of human lupus nephritis a nearly complete loss of heparan sulfate (HS) staining in the glomerular basement membrane (GMB). To clarify the relationship between HS staining and albuminuria in lupus nephritis, we studied MRL/lpr mice with short (< 7 days) or prolonged duration of albuminuria (14-21 days) and compared these with mice of different ages without albuminuria. Kidney sections were stained for mouse immunoglobulin (Ig), HS, heparan sulfate proteoglycan (HSPG)-core protein and laminin in immunofluorescence. In mice with prolonged albuminuria HS staining in the glomerular capillary loops had almost completely disappeared, whereas staining was unaltered in non-albuminuric mice (P = 0.001). In mice with short duration of albuminuria, there was a tendency toward a decrease of HS staining (P = 0.06). The expression of HSPG-core protein and other extra cellular matrix (ECM) components was unaltered in all groups. HS staining correlated inversely with albuminuria (rs = -0.55; P < 0.001) and with staining of Ig deposits in the capillary loops (rs = -0.74; P < 0.001). Despite the nearly complete loss of HS staining in the GBM in mice with prolonged albuminuria, there was no change in glomerular HS content as assessed by agarose electrophoresis and HS inhibition ELISA. We conclude that the development of albuminuria in MRL/lpr mice is accompanied by a loss of HS staining in the GBM, probably due to the masking of HS by deposits of Ig. In vitro studies revealed that autoantibodies complexed to nucleosomal antigens can inhibit the binding of the anti-HS monoclonal antibody to HS. Whether this also occurs in vivo remains to be determined.
This article has been cited by other articles:
![]() |
J. W. A. M. Celie, R. M. Reijmers, E. M. Slot, R. H. J. Beelen, M. Spaargaren, P. M. ter Wee, S. Florquin, and J. van den Born Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria Am J Physiol Renal Physiol, January 1, 2008; 294(1): F253 - F263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Rops, M. J. van den Hoven, M. A. Bakker, J. F. Lensen, T. J. Wijnhoven, L. P. van den Heuvel, T. H. van Kuppevelt, J. van der Vlag, and J. H. Berden Expression of glomerular heparan sulphate domains in murine and human lupus nephritis Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1891 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. I. RAATS, M. E. LUCA, M. A. H. BAKKER, A. VAN DER WAL, P. HEERINGA, H. VAN GOOR, J. VAN DEN BORN, E. DE HEER, and J. H. M. BERDEN Reduction in Glomerular Heparan Sulfate Correlates with Complement Deposition and Albuminuria in Active Heymann Nephritis J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1689 - 1699. [Abstract] [Full Text] |
||||
![]() |
C. J. I. Raats, M. A. H. Bakker, J. van den Born, and J. H. M. Berden Hydroxyl Radicals Depolymerize Glomerular Heparan Sulfate in Vitro and in Experimental Nephrotic Syndrome J. Biol. Chem., October 17, 1997; 272(42): 26734 - 26741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |